High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass

Annals of Thoracic Surgery

Volumn 93, Issue 1, 2012, Pages 148-154

  Kalavrouziotis, Dimitri ^a   Voisine, Pierre ^a   Mohammadi, Siamak ^a   Dionne, Stephanie ^a   Dagenais, Francois ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; PHENYTOIN; TRANEXAMIC ACID;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; HUMAN; KIDNEY FAILURE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OPEN HEART SURGERY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SEIZURE;

AGED; ANTIFIBRINOLYTIC AGENTS; CARDIOPULMONARY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; INCIDENCE; INFUSIONS, INTRAVENOUS; INTRAOPERATIVE PERIOD; MAGNETIC RESONANCE IMAGING; MALE; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; QUEBEC; RETROSPECTIVE STUDIES; RISK FACTORS; SEIZURES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TRANEXAMIC ACID;

EID: 84055192250     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2011.07.085     Document Type: Article

References (32)

1. A.F. Later, J.J. Maas, F.H. Engbers Tranexamic acid and aprotinin in low and intermediate-risk cardiac surgery: a nonsponsored, double blind, randomized, placebo-controlled trial Eur J Cardiothorac Surg 36 2009 322 329
2. S. Senay, F. Toraman, H. Karabulut, C. Alhan Efficiency of preoperative tranexamic acid in coronary artery bypass surgery: an analysis correlated with preoperative clopidogrel use Heart Surg Forum 13 2010 E149 E154
3. D.A. Fergusson, P.C. Hebert, C.D. Mazer A comparison of aprotinin and lysine analogues in high-risk cardiac surgery N Engl J Med 358 2008 2319 2331 (Pubitemid 351749156)
4. V.A. Ferraris, J.R. Brown, G.J. Despotis 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines Ann Thorac Surg 91 2011 944 982
5. W. Dietrich, M. Spannagl, J. Boehm Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin Anesth Analg 107 2008 1469 1478
6. J.M. Karski, N.P. Dowd, R. Joiner The effect of three different doses of tranexamic acid on blood loss after cardiac surgery with mild systemic hypothermia (32 degrees C) J Cardiothorac Vasc Anesth 12 1998 642 646 (Pubitemid 29001680)
7. K. Martin, G. Wiesner, T. Breuer, R. Lange, P. Tassani The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients Anesth Analg 107 2008 1783 1790
8. J.M. Murkin, F. Falter, J. Granton, B. Young, C. Burt, M. Chu High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients Anesth Analg 110 2010 350 353
9. C. Keyl, R. Uhl, F. Beyersdorf High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement Eur J Cardiothorac Surg 39 2011 e114 e121
10. A.L. Shroyer, M.E. Plomondon, F.L. Grover, F.H. Edwards The 1996 coronary artery bypass risk model: the Society of Thoracic Surgeons Adult Cardiac National Database Ann Thorac Surg 67 1999 1205 1208 (Pubitemid 29238334)
11. S. Martens, K. Neumann, C. Sodemann, H. Deschka, G. Wimmer-Greinecker, A. Moritz Carbon dioxide field flooding reduces neurologic impairment after open heart surgery Ann Thorac Surg 85 2008 543 547
12. S. Giordano, F. Biancari Does the use of carbon dioxide field flooding during heart valve surgery prevent postoperative cerebrovascular complications? Interact Cardiovasc Thorac Surg 9 2009 323 326
13. K. Jensen, H.H. Muller, H. Schafer Regional confidence bands for ROC curves Stat Med 19 2000 493 509 (Pubitemid 30126880)
14. S. Lemeshow, D.W. Hosmer A review of goodness of fit statistics for use in the development of logistic regression models Am J Epidemiol 115 1982 92 106 (Pubitemid 12205725)
15. P. Rosenbaum, D. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 41 55
16. W. Arkaravichien, J. Tamungklang, T. Arkaravichien Cefazolin-induced seizures in hemodialysis patients J Med Assoc Thai 89 2006 1981 1983
17. S.A. Tsementzis, E.R. Hitchcock, C.H. Meyer Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms A double-blind placebo-controlled study Acta Neurochir (Wien) 102 1990 1 10 (Pubitemid 20043285)
18. H. Fodstad, A. Forssell, B. Liliequist, M. Schannong Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial Neurosurgery 8 1981 158 165 (Pubitemid 11142228)
19. R. Furtmuller, M.G. Schlag, M. Berger Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid (A) receptor antagonistic effect J Pharmacol Exp Ther 301 2002 168 173 (Pubitemid 34256345)
20. M.G. Schlag, R. Hopf, H. Redl Convulsive seizures following subdural application of fibrin sealant containing tranexamic acid in a rat model Neurosurgery 47 2000 1463 1467
21. G.D. Slapo, M.I. Lossius, L. Gjerstad Poststroke epilepsy: occurrence, predictors and treatment Expert Rev Neurother 6 2006 1801 1809 (Pubitemid 46021066)
22. M.E. Lancman, A. Golimstok, J. Norscini Risk factors for developing seizures after a stroke Epilepsia 34 1993 141 143 (Pubitemid 23045078)
23. H. Wallace, S.D. Shorvon, R. Tallis Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2 052 922 and age-specific fertility rate of women with epilepsy Lancet 352 1998 1790 1793
24. M. Sander, C.D. Spies, V. Martiny, C. Rosenthal, K.D. Wernecke, C. von Heymann Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis Crit Care 14 2010 R148
25. A.T. Santos, R.A. Kalil, C. Bauemann, J.B. Pereira, I.A. Nesralla A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting Braz J Med Biol Res 39 2006 63 69 (Pubitemid 43091529)
26. D.L. Ngaage, M.J. Bland Lessons learned from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomized and large matched observational studies Eur J Cardiothor Surg 37 2009 1375 1383
27. A. Koster, U. Schirmer Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era Curr Opin Anaesthesiol 24 2011 92 97
28. B.K. Fiechtner, G.A. Nuttall, M.E. Johnson Plasma tranexamic acid concentrations during cardiopulmonary bypass Anesth Analg 92 2001 1131 1136 (Pubitemid 32385930)
29. J.C. Horrow, D.F. Van Riper, M.D. Strong, K.E. Grunewald, J.L. Parmet The dose-response relationship of tranexamic acid Anesthesiology 82 1995 383 392
30. N.P. Dowd, J.M. Karski, D.C. Cheng Pharmacokinetics of tranexamic acid during cardiopulmonary bypass Anesthesiology 97 2002 390 399 (Pubitemid 34847752)
31. M.V. Kalpokas, I.K. Nixon, R. Kluger, D.S. Beilby, B.S. Silbert Carbon dioxide field flooding versus mechanical de-airing during open-heart surgery: a prospective randomized controlled trial Perfusion 18 2003 291 294 (Pubitemid 37369284)
32. 2 insufflation on the number and behavior of air microemboli in open-heart surgery: a randomized clinical trial Circulation 109 2004 1127 1132 (Pubitemid 38337407)